1 completed, 1 unknown. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
Follow Sintilimab: new trials by email Literature Review of Sintilimab trials Research Report on Sintilimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma bTAE-HAIC, Lenvatinib, Sintilimab - Liver Diseases, Hepatocellular Carcinoma | Not applicable | Unknown | Sun Yat-sen University | 30 | 2024-05-20 | 2024-08-09 |
| HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT Hepatic arterial infusion chemotherapy, Lenvatinib, Sintilimab - Carcinoma, Hepatocellular, Liver Neoplasms | Not applicable | Completed | Sun Yat-sen University | 30 | 2021-01-01 | 2024-03-06 |
Carcinoma, Hepatocellular (2) · Liver Diseases (1) · Liver Neoplasms (1)
Adenocarcinoma (2) · Carcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Liver Diseases (1) · Liver Neoplasms (1)
Antibodies (2) · lenvatinib (2) · sintilimab (2)
China (2)
Jinhua Huang, Professor (1) · Kangshun Zhu, MD (1) · Zhimei Hunag, MD (1)